Instruction to Authors  by unknown
1. Manuscript Submission
Manuscripts may be submitted by e-mail to: submit@aplcgg.
org 
1.1. Important Information
•   Articles should be in Microsoft Word document format 
and prepared in the simplest form possible. We will add 
in the correct font, font size, margins and so on according 
to the journal’s style.
•   You may use automatic page numbering, but do NOT use 
other kinds of automatic formatting such as footnotes, 
endnotes, headers and footers.
•   Put text, references, tables, and table/figure legends in 
one file.
•   Figures must be submitted separately as picture files, at 
the correct resolution of a minimum of 300 dpi. The files 
should be named according to the figure number and 
format, e.g., “Fig1.tif”, “Fig2.jpg”.
1.2. Supporting Documents
The following documents must be included (refer also to 
the checklist that follows these author instructions):
(1) Cover Letter. This must include the name, address, 
telephone and fax numbers, and e-mail address of the 
corresponding author, and state that all authors have 
contributed to the work and approved the final version 
submitted, and that the submitted manuscript, in whole 
or in part, has not been previously published or submitted 
to other journals simultaneously.
(2) Conflict of Interest Statement. See the relevant section 
below.
(3) Ethics Statement. Articles covering the use of animal or 
human samples in research, or animal or human experi-
ments must be accompanied by a letter of approval from 
the relevant review committee or authorities. Also see the 
relevant section below.
(4) Copyright Transfer Agreement. You may use the form that 
follows these author instructions. The signed statement 
should be scanned and e-mailed to the Editorial Office.
(5) Articles where human subjects can be identified in 
descriptions, photographs or pedigrees must be accompa-
nied by a signed statement of informed consent to publish 
(in print and online) the descriptions, photographs and 
pedigrees from each subject who can be identified. Also 
see the relevant section below.
(6) Where material has been reproduced or adapted from 
other copyrighted sources, the letter(s) of permission from 
the copyright holder(s) to use the copyrighted sources 
must be supplied.
2. Disclosure of Conflicts of Interest
All authors are required to sign and submit the following 
financial disclosure statement at the time of manuscript 
submission:
I certify that all my affiliations with or financial involve-
ment in, within the past 5 years and foreseeable future, 
any organization or entity with a financial interest in or 
financial conflict with the subject matter or materials dis-
cussed in the manuscript are completely disclosed (e.g., 
employment, consultancies, honoraria, stock ownership 
or options, expert testimony, grants or patents received or 
pending, royalties).
Authors who have no relevant financial interests should 
provide a statement indicating that they have no financial 
interests related to the material in the manuscript. Any 
non-financial conflicts of interest should also be explicitly 
declared in your own words.
3. Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, 
appropriate institutional review board or ethics 
committee approval is required, and such approval should 
be stated in the methods section of the manuscript. For 
those investigators who do not have formal ethics review 
committees, the principles outlined in the Declaration of 
Helsinki should be followed (World Medical Association. 
Declaration of Helsinki: Ethical Principles for Medical 
Research Involving Human Subjects. Available at: http://
www.wma.net/en/30publications/10policies/b3/17c. pdf).
For investigations of human subjects, state explicitly 
in the methods section of the manuscript that informed 
consent was obtained from all participating adult subjects 
and from parents or legal guardians for minors or 
incapacitated adults, together with the manner in which 
informed consent was obtained (ex. oral or written). For work 
involving experimental animals, the guidelines for the 
care and use of the animals that were followed should be 
included in the methods section of the manuscript.
4. Identification of Patients in Descriptions, Photographs 
and Pedigrees
A signed statement of informed consent to publish (in 
print and online) patient descriptions, photographs and 
pedigrees should be obtained from all subjects (parents 
or legal  guardians for minors) who can be identified 
(including by the subjects themselves) in such written 
descriptions, photographs or  pedigrees. Such persons 
should be shown the manuscript before its submission. 
Omitting data or making data less specific to de-identify 
patients is acceptable, but changing any such data is not 
acceptable.
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5. Previous Publication or Duplicate Submission
Submitted manuscripts are considered with the understanding 
that they have not been published previously in print or 
electronic format (except in abstract or poster form) and 
are not under consideration in totality or in part by another 
publication or electronic medium.
6. Basic Criteria
Articles should be written in English (using American 
English spelling) and meet the following basic criteria: 
the material is original, the information is important, 
the writing is clear and concise, the study methods are 
appropriate, the data are valid, and the conclusions are 
reasonable and supported by the data.
7. Article Categories
7.1. Review and Systematic Review Articles
These should aim to provide the reader with a balanced 
overview of an important and topical subject in the field, 
and should be systematic and critical assessments of literature 
and data sources. They should cover aspects of a topic in 
which scientific consensus exists as well as aspects that 
remain controversial and are the subject of ongoing scientific 
research. All articles and data sources reviewed should 
include information about the specific type of study or 
analysis, population, intervention, exposure, and tests or 
outcomes. All articles or data sources should be selected 
systematically for inclusion in the review and critically 
evaluated. The text (including references) should not exceed 
4500 words. 
7.2. Editorials
Editorials are invited articles or comments concerning 
a specific paper in the Journal. They should be limited to 
1500 words with no more than 15 references. Although 
editorials are normally invited, unsolicited editorials may 
be submitted.
7.3. Original Articles
These may be randomized trials, intervention studies, 
studies of screening and diagnostic tests, laboratory and 
animal studies, cohort studies, cost-effectiveness analyses, 
case-control studies, and surveys with high response rates, 
which represent new and significant contributions to the 
field.
Section headings should be: Abstract, Introduction, 
Methods, Results, Discussion, Acknowledgments (if applicable), 
References.
The Introduction should provide a brief background 
to the subject of the paper, explain the importance of the 
study, and state a precise study question or purpose.
The Methods section should describe the study design 
and methods (including the study setting and dates, patients/
participants with inclusion and exclusion criteria, or data 
sources and how these were selected for the study, patient 
samples or animal specimens used, explain the laboratory 
methods followed), and state the statistical procedures 
employed in the research.
The Results section should comprise the study results 
presented in a logical sequence, supplemented by tables 
and/or figures. Take care that the text does not repeat data 
that are presented in the tables and/or figures. Only emphasize 
and summarize the essential features of any interventions, 
the main outcome measures, and the main results.
The Discussion section should be used to emphasize 
the new and important aspects of the study, placing the 
results in context with published literature, the implications 
of the findings, and the conclusions that follow from the 
study results.
The text (including references) should not exceed 3500 
words.
7.4. Brief Communications
These should clearly and concisely describe clinical or 
technical notes, preliminary experimental results or in-
strumentation and analytic techniques. Section headings 
should be: Abstract, Introduction, Methods, Results, Dis-
cussion, Acknowledgments (if applicable), References. The 
text should not exceed 2000 words with no more than 20 
references. The Editors reserve the right to decide what 
constitutes a Brief Communication.
7.5. Case Reports
These are short discussions of a case or case series with 
unique features not previously described that make an 
important teaching point or scientific observation. They 
may describe novel techniques, novel use of equipment, or 
new information on diseases of importance. Section head-
ings should be: Abstract, Introduction, Case Presentation, 
Discussion, Acknowledgments (if applicable), References.
The Introduction should describe the purpose of the 
report, the significance of the disease and its specificity, 
and briefly review the relevant literature.
The Case Presentation should include the general 
data of the case, medical history, family history, chief 
complaint, present illness, clinical manifestation, methods 
of diagnosis and treatment, and outcome.
The Discussion should compare, analyze and discuss 
the similarities and differences between the reported case 
and similar previously reported cases. The importance or 
specificity of the case should be restated when discussing the 
differential diagnoses. Suggest the prognosis of the disease 
and possibility of prevention.
The text (including references) should not exceed 2000 
words.
7.6. Letters to the Editor
These include brief constructive comments concerning 
previously published articles, interesting cases that do not 
meet the requirement of being truly exceptional, and other 
communications of general interest. Letters should have a 
title and include appropriate references, and include the 
corresponding author’s mailing and e-mail addresses. Letters 
are edited, sometimes extensively, to sharpen their focus. 
They may be sent for peer review at the discretion of the 
Editors. The text should not exceed 600 words with no more 
than 5 references; 1 table and/or 1 figure may be included.
8. Manuscript Preparation
Text should be typed double-spaced on one side of white 
A4 (297 ¥ 210 mm) paper, with outer margins of 2.5 cm. 
Each section of the manuscript should begin on a new 
page. Pages should be numbered consecutively, beginning 
with the title page.
8.1. Title Page
The title page should contain the following information (in 
order, from the top to the bottom of the page):
• category of paper
• article title
•  names (spelled out in full)* and academic degrees of all 
the authors, and the institutions with which they are af-
filiated; indicate all affiliations with a superscript lowercase 
letter after the author’s name and in front of the appro-
priate affiliation
•  corresponding author details (name, e-mail, mailing 
address, telephone and fax numbers)
*The name of each author should be written with the family name 
last, e.g.,  Jing-Long Huang. Authorship is restricted only to direct 
participants who have contributed significantly to the work. 
8.2. Abstracts
Abstracts should be no more than 300 words in length. 
Abstracts for Original Articles should be structured, with 
the section headings: Background/Purpose, Methods, Results, 
Conclusion. Abstracts for Case Reports are unstructured, 
but should include the significance and purpose of the case 
presentation, the diagnostic methods of the case, the key 
data, and brief comments and suggestions with regard to 
the case. For all article categories, 3–5 relevant key words 
(MeSH index terms) should also be provided in alphabeti-
cal order.
8.3. Main Text
The text for Original Articles should be organized into the fol-
lowing sections: Introduction, Methods, Results, Discussion. 
Sections for Case Reports are: Introduction, Case Presentation, 
Discussion. Each section should begin on a new page.
8.3.1. Abbreviations
Where a term/definition will be continually referred to, it 
must be written in full when it first appears in the text, 
followed by the subsequent abbreviation in parentheses. 
Thereafter, the abbreviation may be used. Restrict the 
number of abbreviations to those that are absolutely necessary.
8.3.2. Units
Système International (SI) units must be used, with the 
exception of blood pressure values which are to be reported in 
mmHg. Use the metric system for the expression of length, 
area, mass, and volume. Temperatures are to be given in 
degrees Celsius.
8.3.3. Names of drugs, devices and other products
Use the Recommended International Non-propri-
etary Name for medicinal substances, unless the 
specific trade name of a drug is directly relevant to the 
discussion. For devices and other products, the generic term 
should be used, unless the specific trade name is directly 
relevant to the discussion. If the trade name is given, then the 
manufacturer name and the city, state and country location 
of the manufacturer must be provided.
8.3.4. Statistical requirements
Statistical analysis is essential for all research papers 
except Case Reports. Use correct nomenclature for 
statistical methods (e.g., two sample t test, not un-
paired t test). Descriptive statistics should follow the 
scales used in data description. Inferential statistics are 
important for interpreting results and should be described in 
detail.
All p values should be presented to the third decimal 
place for accuracy, unless they are less than 0.001. The 
smallest p value that should be expressed is p < 0.001, 
since additional zeros do not convey useful information; 
the largest p value that should be expressed is p > 0.99.
8.3.5. Personal communications and unpublished data
These sources cannot be included in the references list but 
may be described in the text. The author(s) must give the 
full name and highest academic degree of the person, the 
date of the communication, and indicate whether it was 
in oral or written (letter, fax, e-mail) form. A signed state-
ment of permission should be included from each person 
identified as a source of information in a personal commu-
nication or as a source for unpublished data.
8.3.6. Acknowledgments
General acknowledgments for consultations, statistical 
analysis, etc., should be listed concisely at the end of the 
text, including the names of the individuals who were 
directly involved. Consent should be obtained from those 
individuals before their names are listed in this section. All 
financial and material support for the research and work 
from internal or external agencies, including commercial 
companies, should be clearly and completely identified. 
Ensure that any conflicts of interest (financial and/or non-
financial) are explicitly declared.
8.4. References
8.4.1. In the main text, tables and figure legends
•  References should be identified using superscripted num-
bers, in numerical order, and be placed after punctuation.
•  References cited in tables or figure legends should be in-
cluded in sequence at the point where the table or figure 
is first mentioned in the main text.
•  Do not cite abstracts unless they are the only available 
reference to an important concept.
8.4.2. In the references section
•  References should be limited to those cited in the text 
and listed in numerical order, NOT alphabetical order.
•  References should include, in order, author names, arti-
cle title, journal name, year, volume and inclusive page 
numbers. The last names and initials of all the authors 
up to 6 should be included, but when authors number 7 
or more, list the first 6 authors only followed by “et al”. 
Abbreviations for journal names should conform to those 
used in MEDLINE.
•  If citing a website, provide the author information, article 
title, website address and the date you accessed the 
information.
•  Reference to an article that is in press must state the jour-
nal name and, if possible, the year and volume.
Authors are responsible for the accuracy and completeness of 
their references and for correct text citation.
Examples are given below.
Standard journal article
Chen Z, Fan M, Bian Z, Zhang Q, Zhu Q, Lu P. Immunolocali-
zation of heat shock protein 70 during reparative dentino-
genesis. Chin J Dent Res 2000;3:50–5.
Journal supplement
Kaplan NM. The endothelium as prognostic factor and 
therapeutic target: what criteria should we apply? 
J Cardiovasc Pharmacol 1998;32(Suppl 3):S78–80.
Journal article not in English but with English abstract
Kawai H, Ishikawa T, Moroi J, Hanyu N, Sawada M, Koba-
yashi N, et al. Elderly patient with cerebellar malignant 
astrocytoma. No Shinkei Geka 2008;36:799–805. [In 
Japanese, English abstract]
Book
Bradley EL. Medical and Surgical Management. Philadel-
phia: Saunders, 1982:72–95.
Book chapter in book with editor and edition
Greaves M, Culligan DJ. Blood and bone marrow. In: Un-
derwood JCE, ed. General and Systematic Pathology, 4th ed. 
London: Churchill Livingstone, 2004:615–72.
Item presented at a meeting but not yet published
Khuri FR, Lee JJ, Lippman SM. Isotretinoin effects on head 
and neck cancer recurrence and second primary tumors. 
In: Proceedings from the American Society of Clinical On-
cology, May 31–June 3, 2003; Chicago, IL. Abstract 359.
Item presented at a meeting and published
Cionni RJ. Color perception in patients with UV- or bluelight- 
filtering IOLs. In: Symposium on Cataract, IOL, and Refractive 
Surgery. San Diego, CA: American Society of Cataract and 
Refractive Surgery, 2004. Abstract 337.
Thesis
Ayers AJ. Retention of Resin Restorations by Means of Enamel 
Etching and by Pins. MSD thesis, Indiana University, Indi-
anapolis, 1971.
Website
American Association of Oral and Maxillofacial Surgeons. 
Wisdom Teeth. AAOMS Website. http://www.aaoms.org/
wisdom_teeth.php. Published 2008. Accessed September 
25, 2010.
Company/manufacturer publication/pamphlet
Eastman Kodak Company, Eastman Organic Chemicals. 
Catalog No. 49. Rochester NY: Eastman Kodak, 1977:2–3.
8.5. Tables
Tables should supplement, not duplicate, the text. They 
should have a concise table heading, be self-explana-
tory, and numbered consecutively in the order of their 
citation in the text. Information requiring explana-
tory footnotes should be denoted using superscripted 
lowercase letters: a, b, c, etc. Abbreviations used in the 
table must be defined and placed after the footnotes. 
If you include a block of data or table from another 
source, whether published or unpublished, you must 
acknowledge the original source.
8.6. Figures
The number of figures should be restricted to the minimum 
necessary to support the textual material. They should 
have an informative figure legend and be numbered in the 
order of their citation in the text. All symbols and abbre-
viations should be defined in the legend. Patient identi-
fication should be obscured. All lettering should be done 
professionally and should be in proportion to the drawing, 
graph or photograph. Photomicrographs must include an 
internal scale marker, and the legend should state the type 
of specimen, original magnification and stain.
9. The Editorial and Peer Review Process
As a general rule, the receipt of a manuscript will be ac-
knowledged within 2 weeks of submission; authors will be 
provided with a manuscript reference number for future 
correspondence. If an acknowledgment is not received in a 
reasonable period of time, the author should contact the 
Editorial Office.
Submissions are reviewed by the Editorial Office to en-
sure that it contains all parts. Submissions will be rejected 
if the author has not supplied all the material and docu-
ments as outlined in these author instructions.
Manuscripts are then forwarded to the Editor-in-Chief, 
who makes an initial assessment of it. If the manuscript 
does not appear to be of sufficient merit or is not appro-
priate for the Journal, the manuscript will be rejected 
without review.
Rejected manuscripts will not be returned to authors un-
less requested. All other manuscripts are sent to 2 or more 
expert consultants for double-blind peer review. Authors will 
usually be notified within 8 weeks of the initial acknowledg-
ment of whether the manuscript is accepted for publication, 
rejected, or subject to revision before acceptance. However, 
do note that delays are sometimes unavoidable.
10. Preparation for Publication
Once a manuscript has been accepted for publication, au-
thors should submit the final version of the manuscript (in 
MS Word format, with all tables/figures as applicable) by 
e-mail to: submit@aplcgg.org.
Accepted manuscripts are copyedited according to the 
Journal’s style and PDF page proofs are e-mailed by the 
Publisher to the corresponding author for final approval. 
Authors are responsible for all statements made in their 
work, including changes made by the copy editor.
11. Professional Reprints
Professional reprints (which include a cover page for the 
article) may be ordered from the Publisher at prices based 
on the cost of production. A reprint order form is available 
from www.e-jcgg.com.
12. Copyright
Published manuscripts become the permanent property of the 
Asia Pacific League of Clinical Gerontology and Geriatrics. All ar-
ticles published in the Journal are protected by copyright, which 
covers the exclusive rights to reproduce and distribute the arti-
cle, as well as translation rights. No part of this publication may 
be reproduced, stored in any retrieval system, or transmitted 
in any form or by any means, electronic, mechanical, by pho-
tocopying, recording, or otherwise, without prior written per-
mission from the Asia Pacific League of Clinical Gerontology and 
Geriatrics.
